AbbVie vs Bank of America: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Bank of America was founded in 1904 by Amadeo Peter Giannini and is led by Brian Moynihan.
Company facts
AbbVie
- Founded
- 2013
- Headquarters
- North Chicago, Illinois
- Current CEO
- Robert A. Michael
- Employees
- 57,000
Bank of America
- Founded
- 1904
- Headquarters
- Charlotte, North Carolina
- Current CEO
- Brian Moynihan
- Employees
- 213,000
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Bank of America
Amadeo Peter Giannini
Bank of America was founded by A. P. Giannini, the San Jose-born son of Italian immigrants. In 1904 he opened the Bank of Italy in a converted saloon in San Francisco's North Beach neighborhood. His aim was unusual for the time: to lend to working people.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Bank of America
- Amadeo Peter Giannini1904–1945
Founder and Chairman
Giannini was born in San Jose, California, in 1870 to Italian immigrant parents and sold fruit and vegetables from a horse-drawn wagon before opening the Bank of Italy in San Francisco at the age of 34.
Source - Hugh L. McColl Jr.1998–2001
Chairman and Chief Executive Officer
McColl joined the company in 1959 as a management trainee and built NationsBank through interstate acquisitions before its 1998 combination with San Francisco based BankAmerica, which took the Bank of America name and created the first coast-to-coast U.S.
Source - Ken Lewis2001–2009
Chairman and Chief Executive Officer
Lewis joined the company in 1969 as a credit analyst, ran corporate strategy from 1999, and became chairman and chief executive officer on April 25, 2001 when Hugh McColl retired.
Source - Brian Moynihan2010–present
Chair of the Board and Chief Executive Officer
Moynihan became chief executive officer on January 1, 2010, after running the general counsel, consumer banking and wealth management units, and he also chairs the board.
Source
Timeline: AbbVie and Bank of America side by side
1904Bank of America
Bank of Italy Founded
A.P. Giannini founded the Bank of Italy in San Francisco to expand access to banking for immigrants, wage earners, and small merchants.
1906Bank of America
San Francisco Earthquake Response
After the 1906 earthquake, Giannini resumed lending while much of San Francisco's banking system was disrupted. The response turned emergency access to credit into lasting customer trust and became a defining story in the bank's retail identity.
1930Bank of America
Bank of Italy Renamed Bank of America
The Bank of Italy changed its name to Bank of America on November 1, 1930. The rebrand reflected a wider consumer and business ambition beyond the original immigrant-community label.
1958Bank of America
BankAmericard Introduced
Bank of America introduced BankAmericard in 1958, a revolving-credit card that later became part of the Visa system. The product tied the bank to modern consumer credit, merchant acceptance, and payment-network economics.
1998Bank of America
NationsBank and BankAmerica Merge
The 1998 merger of Charlotte-based NationsBank and San Francisco's BankAmerica created the first coast-to-coast U.S. bank under the Bank of America name. It also shifted the modern company's headquarters center to Charlotte.
2006Bank of America
MBNA Merger Completed
The MBNA merger expanded the card business to more than 40M active accounts and nearly $140B in managed balances, according to the company's January 2006 release. That size made cards a more important part of consumer banking revenue and risk.
2008Bank of America
Countrywide Acquisition Approved
The Federal Reserve approved Bank of America's acquisition of Countrywide in June 2008. The deal added mortgage scale but later became a costly warning about buying distressed loan portfolios during a housing crisis.
2008Bank of America
Merrill Lynch Acquisition Approved
The Federal Reserve approved the acquisition of Merrill Lynch in November 2008. Although the integration was controversial, Merrill became central to the company's wealth-management and investment-banking fee base.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2014Bank of America
Mortgage Settlements With the Justice Department and FHFA
Bank of America agreed in August 2014 to a $16.65B settlement with the Justice Department over mortgage claims tied to Countrywide and Merrill Lynch, following a March 2014 FHFA agreement with an aggregate payment of about $9.33B.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2018Bank of America
Erica Launched
Bank of America launched Erica in 2018 as an AI-enabled virtual assistant inside digital banking. The launch mattered because customer service, insights, and routine account tasks were moving from branches and call centers into mobile channels.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023Bank of America
CFPB and OCC Orders on Fees, Rewards and Accounts
In July 2023 the CFPB ordered Bank of America to pay more than $100M to customers for repeat non-sufficient-funds fees, withheld credit card rewards and unauthorized accounts, plus $90M in CFPB penalties, and the OCC added a $60M penalty.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Bank of America
$113.1B FY2025 Revenue
The company reported $113.1B in total revenue net of interest expense and $30.5B in net income for FY2025. The result showed the combined scale of deposits, wealth management, cards, payments, global banking, and markets.
2025Bank of America
Co-Presidents Named
On September 12, 2025 Bank of America named Dean Athanasia and Jim DeMare Co-Presidents and gave Chief Financial Officer Alastair Borthwick the added title of executive vice president.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Bank of America
- Countrywide Financial2008$4B
- Merrill Lynch2008$50B
- LaSalle Bank2007$21B
- MBNA2006$35B
- FleetBoston Financial2004$47B
- BankAmerica / NationsBank merger1998$43B
Questions about AbbVie vs Bank of America
Who is the CEO of AbbVie Inc. and Bank of America Corporation?
AbbVie Inc. is led by Robert A. Michael and Bank of America Corporation is led by Brian Moynihan. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Bank of America Corporation?
Bank of America Corporation was founded in 1904 — 109 years before AbbVie Inc., which was founded in 2013. Bank of America Corporation's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Bank of America Corporation?
AbbVie Inc. employs approximately 57,000 people, while Bank of America Corporation employs approximately 213,000. Bank of America Corporation has the larger workforce at 213,000 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Bank of America Corporation headquartered?
Both AbbVie Inc. and Bank of America Corporation are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Bank of America Corporation?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Bank of America Corporation was founded by Amadeo Peter Giannini.
Which company has a longer operating history — AbbVie Inc. or Bank of America Corporation?
Bank of America Corporation has been operating for approximately 122 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Bank of America overview